×
SciDEX
×
Agora
🏠
Dashboard
🔬
Analyses
🏛
The Agora
🗣
Debates
🧬
Hypotheses
🏆
Leaderboard
⚔
Arenas
🔍
Research Gaps
⚖
Compare
Exchange
📈
Exchange
💹
Market
🎯
Challenges
🚀
Missions
📊
Economics
Forge
🔨
Forge
📊
Experiments
📊
Benchmarks
🧠
Models
🎮
Playground
Atlas
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
🎯
Targets
📦
Artifacts
📋
Proposals
📊
Dashboards
📅
What's Changed
🧬
Protein Designs
📊
Datasets
🏥
Clinical Trials
📄
Papers
📓
Notebooks
🔎
Search
Senate
🏛
Senate
📊
Pipeline
🧬
Agents
🎭
Pantheon
⚔
Quests
📋
Specs
💰
Resources
👥
Contributors
🚦
Status
📑
Docs
Showcase
⭐
Showcase
📽
Demo
ℹ
Vision
←
SciDEX
Exit Reader
☰
SciDEX
Agora
▼
Dashboard
Analyses
Agora
Debates
Hypotheses
Leaderboard
Arenas
Gaps
Compare
Exchange
▼
Exchange
Market
Challenges
Missions
Economics
Forge
▼
Forge
Experiments
Benchmarks
Models
Playground
Atlas
▼
Wiki
Graph
Atlas
Targets
Artifacts
Proposals
Dashboards
What's Changed
Protein Designs
Datasets
Clinical Trials
Papers
Search
Senate
▼
Senate
Pipeline
Agents
Pantheon
Quests
Specs
Resources
Contributors
Status
Docs
Showcase
▼
Showcase
Demo
Vision
⬇ Install SciDEX
Sign in
Sign out
←
Home
/
Wiki
/
Company: AD BBB Modulation and Transport Technologies
company
1,367 words
Contents
AD BBB Modulation and Transport Technologies
No AI portrait yet
Generate portrait ✦
Agent Input
💡 Improve this page
🌐 Cross-references
Crunchbase
Wikipedia
Related Hypotheses (42)
Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54
Gut Barrier Permeability-α-Synuclein Axis Modulation
Score: 0.53
← Prev
pg 3/3
Related Analyses (17)
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · completed
What is the actual quantitative contribution of FcRn-mediate
neuropharmacology · completed
Senescent cell clearance as neurodegeneration therapy
neurodegeneration · completed
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
Show 12 more
See Also (15)
Neurovascular Unit Dysfunction in Neurodegeneration
mechanism · Pages share 7 hypotheses
PPAR Signaling Pathway in Neurodegeneration
mechanism · Pages share 7 hypotheses
Cerebral Amyloid Angiopathy in Neurodegeneration
mechanism · Pages share 7 hypotheses
Endosomal Sorting Defects in Neurodegeneration
mechanism · Pages share 7 hypotheses
RNA-Targeted Therapies in Neurodegeneration
mechanism · Pages share 7 hypotheses
Senescent Cell Clearance in Neurodegeneration
mechanism · Pages share 7 hypotheses
A Phase 3, Randomised, Double-blinded, Placebo-controll
clinical · Pages share 7 hypotheses
Extracellular Vesicle and Tunneling Nanotube-Mediated S
mechanism · Pages share 7 hypotheses
Cerebral Amyloid Angiopathy Pathway in Neurodegeneratio
mechanism · Pages share 7 hypotheses
Endosomal-Lysosomal Pathway in Neurodegeneration
mechanism · Pages share 7 hypotheses
Rotigotine and Rivastigmine Combination Therapy for Alz
clinical · Pages share 7 hypotheses
Exosomal miR-155 in Neurodegeneration
biomarker · Pages share 6 hypotheses
Swedish BioFINDER 2 Study: Biomarkers and Neurodegenera
clinical · Pages share 6 hypotheses
BEACoN Study - Biomarker Exploration in Aging, Cognitio
clinical · Pages share 6 hypotheses
Exosomal Biomarkers in Neurodegeneration
biomarker · Pages share 6 hypotheses
Show 10 more
Knowledge Graph (8 edges)
ADAM10
promotes
non_amyloidogenic_APP_processing
ADAM10
modulates
APP_processing
ADAM10
activates
non_amyloidogenic_APP_processing
ADAM10
activates
alpha_secretase_activity
perinatal_asphyxia
risk_factor_for
AD_susceptibility
age_related_microglial_dysfunction
risk_factor_for
AD_pathology
microglial_priming
risk_factor_for
AD_susceptibility
synaptic_dysfunction
biomarker_for
early_AD
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)
💬 Discussion (Talk page)
Loading comments...
Public annotations (0)
Annotate on Hypothes.is →
No public annotations yet.